立方制药
(003020)
| 流通市值：24.92亿 | | | 总市值：34.52亿 |
| 流通股本：1.38亿 | | | 总股本：1.91亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 319,783,092.31 | 267,767,285.21 | 187,746,356.52 | 502,928,970.18 |
| 应收票据及应收账款 | 357,146,880.09 | 354,610,757.18 | 282,387,801.2 | 259,239,324.51 |
| 其中：应收票据 | - | - | 200,000 | 792,000 |
| 应收账款 | 357,146,880.09 | 354,610,757.18 | 282,187,801.2 | 258,447,324.51 |
| 应收款项融资 | 45,223,235.33 | 33,284,332.53 | 30,413,038.32 | 35,946,606.26 |
| 预付款项 | 24,593,435.66 | 22,224,545.5 | 43,066,983 | 9,359,458.77 |
| 其他应收款合计 | 15,336,614.75 | 14,690,385.1 | 20,722,535.31 | 19,973,528.21 |
| 应收股利 | - | - | 4,956,463.07 | 4,956,463.07 |
| 存货 | 209,906,611.38 | 220,410,196.41 | 231,136,836.5 | 242,914,365.17 |
| 其他流动资产 | 18,164,854.78 | 20,310,116.1 | 21,890,451.29 | 19,264,693.94 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,158,018,371.95 | 1,091,196,861.68 | 1,139,856,414.52 | 1,151,146,569.82 |
| 非流动资产: | | | | |
| 长期股权投资 | 176,061,029.92 | 169,623,694.93 | 169,598,898.44 | 163,951,200.01 |
| 其他权益工具投资 | 19,439,136.58 | 16,439,136.58 | 16,439,136.58 | 16,439,136.58 |
| 投资性房地产 | 25,028,049.48 | 25,224,452.61 | 25,420,855.74 | 25,617,258.87 |
| 固定资产 | 710,029,543.5 | 587,734,116.34 | 415,532,220.59 | 427,255,044.92 |
| 在建工程 | 223,424,163.87 | 333,441,033.43 | 485,378,763.71 | 459,661,247.6 |
| 生产性生物资产 | 2,417,554.17 | 2,417,554.17 | 2,406,183.06 | 2,403,399.61 |
| 使用权资产 | 11,408,725.02 | 12,821,329.27 | 8,095,781.83 | 9,300,017.93 |
| 无形资产 | 106,869,261.64 | 109,004,209.74 | 110,955,626.18 | 113,285,091.8 |
| 开发支出 | 2,502,000 | 2,586,000 | 2,824,709.22 | 2,084,400 |
| 商誉 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 |
| 长期待摊费用 | 4,374,050.46 | 4,945,574.7 | 5,712,657.37 | 5,324,735.71 |
| 递延所得税资产 | 18,485,161.58 | 15,881,231.29 | 15,731,648.67 | 16,129,089.54 |
| 其他非流动资产 | 22,326,396.75 | 38,148,830.27 | 21,979,108.17 | 16,641,861.86 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,396,805,593.89 | 1,392,707,684.25 | 1,354,516,110.48 | 1,332,533,005.35 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,554,823,965.84 | 2,483,904,545.93 | 2,494,372,525 | 2,483,679,575.17 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 328,118,034.48 | 340,436,259.85 | 308,242,645.07 | 301,250,508.41 |
| 其中：应付票据 | - | - | - | 0 |
| 应付账款 | 328,118,034.48 | 340,436,259.85 | 308,242,645.07 | 301,250,508.41 |
| 预收款项 | - | - | - | 276,402.45 |
| 合同负债 | 15,570,255.08 | 11,917,505.14 | 16,346,697.07 | 10,707,378.82 |
| 应付职工薪酬 | 29,085,428.79 | 22,905,514.1 | 18,829,448.36 | 32,376,327.81 |
| 应交税费 | 34,782,389.33 | 39,248,411.09 | 27,998,122.74 | 35,938,630.14 |
| 其他应付款合计 | 121,201,124.93 | 117,283,381.46 | 142,020,268 | 156,412,962.45 |
| 应付股利 | - | - | 15,680,000 | 15,680,000 |
| 一年内到期的非流动负债 | 7,184,966.18 | 5,339,444.94 | 4,934,778.2 | 4,537,637.07 |
| 其他流动负债 | 1,861,524.91 | 1,450,495.33 | 1,993,233.47 | 1,229,435.73 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 537,803,723.7 | 538,581,011.91 | 520,365,192.91 | 542,729,282.88 |
| 非流动负债: | | | | |
| 长期借款 | 59,646,667.5 | 31,025,575 | 31,000,000 | 31,014,208.33 |
| 租赁负债 | 2,120,950.66 | 5,121,196.72 | 1,378,014.96 | 2,842,254.77 |
| 递延收益 | 18,271,309.95 | 18,922,137.39 | 19,665,552.45 | 20,163,577.11 |
| 递延所得税负债 | 12,320,544.55 | 11,310,005.81 | 13,136,802.02 | 13,432,237.41 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 92,359,472.66 | 66,378,914.92 | 65,180,369.43 | 67,452,277.62 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 630,163,196.36 | 604,959,926.83 | 585,545,562.34 | 610,181,560.5 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 191,571,763 | 191,571,763 | 159,643,136 | 159,675,100 |
| 资本公积 | 530,912,511.53 | 528,937,051.18 | 555,360,852.93 | 551,889,778.53 |
| 减:库存股 | 20,658,376.8 | 20,658,376.8 | 20,658,376.8 | 20,985,151.32 |
| 盈余公积 | 81,977,401.19 | 81,977,401.19 | 81,977,401.19 | 81,977,401.19 |
| 未分配利润 | 947,902,102.83 | 910,578,560.3 | 938,607,610.5 | 912,969,213.21 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,731,705,401.75 | 1,692,406,398.87 | 1,714,930,623.82 | 1,685,526,341.61 |
| 少数股东权益 | 192,955,367.73 | 186,538,220.23 | 193,896,338.84 | 187,971,673.06 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,924,660,769.48 | 1,878,944,619.1 | 1,908,826,962.66 | 1,873,498,014.67 |
| 负债和股东权益合计 | 2,554,823,965.84 | 2,483,904,545.93 | 2,494,372,525 | 2,483,679,575.17 |
| 公告日期 | 2024-10-30 | 2024-08-31 | 2024-04-30 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |